{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-25-001236","form_type":"8-K","ticker":"PMCB","cik":"0001157075","company_name":"PharmaCyte Biotech, Inc.","filed_at":"2025-02-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.047033+00:00","generated_at":"2026-05-26T03:15:04.159264+00:00","sec_items":["4.01","9.01"],"event_type":"other","sentiment":"negative","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"PharmaCyte Biotech auditor Marcum resigns, replaced by CBIZ CPAs P.C.; material weaknesses reiterated","bullets":["Marcum LLP resigned as independent auditor on Feb 21, 2025, effective upon CBIZ CPAs P.C. acquiring Marcum's attest business.","Audit Committee immediately engaged CBIZ CPAs P.C. as successor independent registered public accounting firm.","No disagreements with Marcum on accounting principles or audit scope during FYE April 30, 2024 or interim period.","Material weaknesses disclosed in prior 10-K remain: insufficient segregation of CFO duties and insufficient management review controls.","Marcum provided letter to SEC agreeing with the company's statements regarding the change."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-25-001236","json":"https://secwatch.observer/filing/0001683168-25-001236.json","markdown":"https://secwatch.observer/filing/0001683168-25-001236.md","text":"https://secwatch.observer/filing/0001683168-25-001236.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1157075/000168316825001236/0001683168-25-001236-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1157075/000168316825001236/pharmacyte_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T03:15:04.159264+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4744cd6c1343c72367799873ebb536b781aba814","claim":"Marcum LLP resigned as auditor of PharmaCyte Biotech, Inc..","evidence_excerpt":"(the “Company”) was notified by Marcum LLP (“Marcum”) that Marcum resigned as the independent registered accounting firm of the Company. Based on information provided by Marcum, effective November 1, 2024, CBIZ CPAs P.C. acquired the attest business of Marcum. On February 21, 2025, the Audit Committee of the Company’s Board of Directors accepted the resignation of Marcum and approved the engagement of CBIZ CPAs P.C.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316825001236/0001683168-25-001236-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"resignation"},{"label":"Auditor","value":"Marcum LLP"},{"label":"Successor","value":"CBIZ CPAs P.C."}],"fact_type":"auditor_change"},{"claim_id":"62466eb2ba57bc42ae13113ed5a03e6fc355e730","claim":"PharmaCyte Biotech, Inc. engaged CBIZ CPAs P.C. as its auditor.","evidence_excerpt":"On February 21, 2025, the Audit Committee of the Company’s Board of Directors accepted the resignation of Marcum and approved the engagement of CBIZ CPAs P.C. to serve as the Company’s independent registered public accounting firm.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316825001236/0001683168-25-001236-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"engagement"},{"label":"Auditor","value":"CBIZ CPAs P.C."}],"fact_type":"auditor_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}